Institutional & Family Asset Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Institutional & Family Asset Management, LLC

  • $846 Million
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$26.2 - $36.08 $235 - $324
9 Added 81.82%
20 $0
Q3 2021

Nov 10, 2021
SELL
$58.38 - $84.96 $467 - $679
-8 Reduced 42.11%
11 $1,000
Q1 2021

May 06, 2021
SELL
$61.35 - $90.47 $736 - $1,085
-12 Reduced 38.71%
19 $1,000
Q4 2020

Feb 03, 2021
SELL
$43.82 - $85.37 $43 - $85
-1 Reduced 3.13%
31 $2,000
Q2 2020

Aug 14, 2020
BUY
$26.12 - $43.27 $208 - $346
8 Added 33.33%
32 $1,000
Q4 2019

Feb 14, 2020
BUY
$28.14 - $73.01 $675 - $1,752
24 New
24 $2,000

Others Institutions Holding ARWR

# of Institutions
304
Shares Held
96.2M
Call Options Held
388K
Put Options Held
420K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.11B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email